CN1903254B - 治疗风热感冒的复方药物及其制备方法 - Google Patents
治疗风热感冒的复方药物及其制备方法 Download PDFInfo
- Publication number
- CN1903254B CN1903254B CN200610111509A CN200610111509A CN1903254B CN 1903254 B CN1903254 B CN 1903254B CN 200610111509 A CN200610111509 A CN 200610111509A CN 200610111509 A CN200610111509 A CN 200610111509A CN 1903254 B CN1903254 B CN 1903254B
- Authority
- CN
- China
- Prior art keywords
- parts
- volatile oil
- medicine
- radix
- compound medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 136
- 150000001875 compounds Chemical class 0.000 title claims description 19
- 238000000034 method Methods 0.000 title abstract description 9
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 80
- 239000000341 volatile oil Substances 0.000 claims description 49
- 229940079593 drug Drugs 0.000 claims description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- 238000000605 extraction Methods 0.000 claims description 20
- 239000008187 granular material Substances 0.000 claims description 20
- 238000002360 preparation method Methods 0.000 claims description 19
- 238000011282 treatment Methods 0.000 claims description 17
- 241000628997 Flos Species 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 239000010231 banlangen Substances 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 10
- 238000004821 distillation Methods 0.000 claims description 7
- -1 soaked reflux Substances 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- 239000004375 Dextrin Substances 0.000 claims description 5
- 229920001353 Dextrin Polymers 0.000 claims description 5
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 5
- 235000019425 dextrin Nutrition 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000002386 leaching Methods 0.000 claims description 5
- 230000002829 reductive effect Effects 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 241000555712 Forsythia Species 0.000 claims description 4
- 241000245240 Lonicera Species 0.000 claims description 4
- 241001072983 Mentha Species 0.000 claims description 4
- 235000014435 Mentha Nutrition 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 4
- 238000003801 milling Methods 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 241000951473 Schizonepeta Species 0.000 claims description 3
- BPYGTFFYYOWDBC-LOVSFRALSA-N arctiin Natural products COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc3ccc(O[C@@H]4O[C@H](C)[C@@H](O)[C@H](O)[C@H]4O)c(OC)c3)cc1OC BPYGTFFYYOWDBC-LOVSFRALSA-N 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 3
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000208843 Arctium Species 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 34
- 241000699670 Mus sp. Species 0.000 description 28
- 241000699666 Mus <mouse, genus> Species 0.000 description 23
- 238000002347 injection Methods 0.000 description 20
- 239000007924 injection Substances 0.000 description 20
- 230000037396 body weight Effects 0.000 description 19
- 210000002784 stomach Anatomy 0.000 description 17
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- 230000036760 body temperature Effects 0.000 description 15
- 238000012360 testing method Methods 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 230000003203 everyday effect Effects 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 10
- 241000194017 Streptococcus Species 0.000 description 10
- 230000002496 gastric effect Effects 0.000 description 10
- 206010022000 influenza Diseases 0.000 description 10
- 238000001802 infusion Methods 0.000 description 10
- 230000036407 pain Effects 0.000 description 10
- 239000002510 pyrogen Substances 0.000 description 10
- 230000008961 swelling Effects 0.000 description 10
- 238000012449 Kunming mouse Methods 0.000 description 9
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 241000193998 Streptococcus pneumoniae Species 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 230000002949 hemolytic effect Effects 0.000 description 8
- 230000001681 protective effect Effects 0.000 description 8
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 8
- 208000000114 Pain Threshold Diseases 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 230000037040 pain threshold Effects 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 6
- 241000191967 Staphylococcus aureus Species 0.000 description 6
- 235000010418 carrageenan Nutrition 0.000 description 6
- 229920001525 carrageenan Polymers 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 201000000297 Erysipelas Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 206010068319 Oropharyngeal pain Diseases 0.000 description 5
- 201000007100 Pharyngitis Diseases 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 241000700605 Viruses Species 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 108010006464 Hemolysin Proteins Proteins 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 241000700157 Rattus norvegicus Species 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 239000003228 hemolysin Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010014025 Ear swelling Diseases 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010057190 Respiratory tract infections Diseases 0.000 description 3
- 206010039101 Rhinorrhoea Diseases 0.000 description 3
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 3
- 208000036142 Viral infection Diseases 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 230000004856 capillary permeability Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 208000010753 nasal discharge Diseases 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000010254 subcutaneous injection Methods 0.000 description 3
- 239000007929 subcutaneous injection Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 230000009385 viral infection Effects 0.000 description 3
- 206010063659 Aversion Diseases 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 208000005647 Mumps Diseases 0.000 description 2
- 241000117280 Naematelia aurantialba Species 0.000 description 2
- 206010028748 Nasal obstruction Diseases 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 238000004500 asepsis Methods 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 208000010805 mumps infectious disease Diseases 0.000 description 2
- 210000002850 nasal mucosa Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- UBCHPRBFMUDMNC-UHFFFAOYSA-N 1-(1-adamantyl)ethanamine Chemical compound C1C(C2)CC3CC2CC1(C(N)C)C3 UBCHPRBFMUDMNC-UHFFFAOYSA-N 0.000 description 1
- IQUPABOKLQSFBK-UHFFFAOYSA-M 2-nitrophenolate Chemical compound [O-]C1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-M 0.000 description 1
- 240000006409 Acacia auriculiformis Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 1
- 101100433727 Caenorhabditis elegans got-1.2 gene Proteins 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 241000709687 Coxsackievirus Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 241000334154 Isatis tinctoria Species 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 206010028735 Nasal congestion Diseases 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 208000035109 Pneumococcal Infections Diseases 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
- 229960003805 amantadine Drugs 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000003907 antipyretic analgesic agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 229960003699 evans blue Drugs 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 229960003447 pseudoephedrine hydrochloride Drugs 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 229960000888 rimantadine Drugs 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000005182 tip of the tongue Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 229940100050 virazole Drugs 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610111509A CN1903254B (zh) | 2006-08-21 | 2006-08-21 | 治疗风热感冒的复方药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610111509A CN1903254B (zh) | 2006-08-21 | 2006-08-21 | 治疗风热感冒的复方药物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1903254A CN1903254A (zh) | 2007-01-31 |
CN1903254B true CN1903254B (zh) | 2010-05-12 |
Family
ID=37672714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200610111509A Expired - Fee Related CN1903254B (zh) | 2006-08-21 | 2006-08-21 | 治疗风热感冒的复方药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1903254B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526517B (zh) * | 2011-12-21 | 2014-06-04 | 南方医科大学珠江医院 | 一种治疗感冒的热毒清中药组合物及其制备方法 |
CN104435796A (zh) * | 2014-10-20 | 2015-03-25 | 安徽华泽医药有限公司 | 一种抗感冒的中药制剂 |
CN107469034A (zh) * | 2017-08-16 | 2017-12-15 | 河南中医药大学 | 一种治疗病毒性感冒的中药 |
CN109260309A (zh) * | 2018-11-20 | 2019-01-25 | 山东罗欣乐康制药有限公司 | 一种温中止痛的中药组合物颗粒剂的制备方法 |
CN114558102A (zh) * | 2022-03-18 | 2022-05-31 | 湖北仙宠生物科技有限公司 | 一种治疗上呼吸道病毒性传染性疾病的中成药配方 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1733148A (zh) * | 2005-08-01 | 2006-02-15 | 刘安西 | 感冒清热退烧中药速释透皮吸收给药贴片 |
-
2006
- 2006-08-21 CN CN200610111509A patent/CN1903254B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1733148A (zh) * | 2005-08-01 | 2006-02-15 | 刘安西 | 感冒清热退烧中药速释透皮吸收给药贴片 |
Non-Patent Citations (12)
Title |
---|
.外感与常见肺系疾病的中医诊断及治疗.社区医学杂志3 4.2005,3(4),29-34. |
.津门名医邢锡波先生内科治验汇萃(一).天津中医学院 |
19 4.2002,19(4),5-6. |
19 4.2002,19(4),5-6.;乐鸣.感冒的病因病机及其辨证分型.实用中医内科杂志·16 4.2004,16(4),187-188. * |
乐鸣.感冒的病因病机及其辨证分型.实用中医内科杂志·16 4.2004,16(4),187-188. |
刘娟.从109例表热看银翘散用药规律.中国中医急症4 6.1995,4(6),275-276. |
刘娟.从109例表热看银翘散用药规律.中国中医急症4 6.1995,4(6),275-276. * |
王光辉 |
王光辉;王琦;.外感与常见肺系疾病的中医诊断及治疗.社区医学杂志3 4.2005,3(4),29-34. * |
王琦 |
魏玉琦 |
魏玉琦;.津门名医邢锡波先生内科治验汇萃(一).天津中医学院 * |
Also Published As
Publication number | Publication date |
---|---|
CN1903254A (zh) | 2007-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101836691B (zh) | 一种中草药饲料添加剂 | |
CN103585433B (zh) | 一种治疗口腔溃疡的中药组合物 | |
CN101396466A (zh) | 一种药食两用感冒药茶组合物及其制备方法和用途 | |
CN101953985A (zh) | 一种具有清肺止咳作用的药物 | |
CN102836228B (zh) | 一种治疗结膜炎的中药组合物及其制备方法和应用 | |
CN1903254B (zh) | 治疗风热感冒的复方药物及其制备方法 | |
CN100353953C (zh) | 治疗口腔、咽喉疾病的中药制剂及其制备方法 | |
CN114073730A (zh) | 一种预防或治疗空调综合征的中药组合物 | |
CN101628108B (zh) | 治疗外感风寒的中药颗粒剂及其制备方法 | |
CN104013846A (zh) | 一种治疗口腔溃疡的中药组合物及其应用 | |
CN102895326B (zh) | 一种治疗小儿感冒的中药组合物及其制备方法 | |
CN103251844B (zh) | 用于清咽润喉的片剂 | |
CN102526573A (zh) | 一种治疗儿童感冒的药物 | |
WO2020155318A1 (zh) | 一种治疗家畜细菌性呼吸道疫病的中药制剂及其生产工艺 | |
CN105726792A (zh) | 一种具有抗牙周炎,保护牙周组织作用的中药组合物及其制备方法与应用 | |
CN101053600B (zh) | 治疗感冒的药物组合物及其制备方法和用途 | |
CN101721614B (zh) | 一种具有清利咽喉和消肿止痛功效的药物组合物 | |
CN106309746A (zh) | 一种中药组合物及其制备方法和口腔保健品 | |
CN103893593B (zh) | 具有清热解毒、抗炎和增强免疫力作用的药物组合物 | |
CN100531757C (zh) | 一种治疗风热型感冒的药物组合物及其制备方法 | |
CN101607032B (zh) | 治疗儿童咳嗽的复方药物及其制备方法 | |
CN103816281A (zh) | 一种预防和治疗风热感冒的中药组合物 | |
CN103142702A (zh) | 治疗猪蓝耳病的中草药注射液及其制备方法 | |
CN113476562A (zh) | 一种组合物及其制备方法和用途 | |
CN100469378C (zh) | 治疗咽炎的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: QINGDAO HANHE PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ZHU HONGLONG Effective date: 20100608 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 266061 B20, NONGHAIYUAN, NO.316, HONG KONG EAST ROAD, QINGDAO CITY, SHANDONG PROVINCE TO: 266061 HANHE VILLAGE, SHAZIKOU SUB-DISTRICT OFFICE, LAOSHAN DISTRICT, QINGDAO CITY, SHANDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20100608 Address after: Laoshan District Shazikou Street office in Shandong Province, Qingdao City, 266061 Chinese Village Patentee after: Qingdao Hanhe Pharmaceutical Co., Ltd. Address before: 266061 Shandong Province, Qingdao city Hongkong Road No. 316 Nonghaiyuan B20 Patentee before: Zhu Honglong |
|
C56 | Change in the name or address of the patentee |
Owner name: QINGDAO HUAHAI PHARMACEUTICAL RESEARCH INSTITUTE C Free format text: FORMER NAME: QINGDAO HANHE PHARMACEUTICAL CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: 266101 Shandong Province, Qingdao city Laoshan District Road No. 17 Keyuan four Building No. 3 Patentee after: QINGDAO HUAHAI PHARMACEUTICAL RESEARCH INSTITUTE CO., LTD. Address before: Laoshan District Shazikou Street office in Shandong Province, Qingdao City, 266061 Chinese Village Patentee before: Qingdao Hanhe Pharmaceutical Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100512 Termination date: 20160821 |
|
CF01 | Termination of patent right due to non-payment of annual fee |